Floatz logo

Cyclophosphamide

Desmoplastic Small Round Cell Tumor

St. Jude Children's Research HospitalSmall moleculePhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Desmoplastic Small Round Cell Tumor cohort.

Asset / SponsorPhaseRating
Fludarabine
St. Jude Children's Research Hospital
Phase 2B
Imatinib
National Cancer Institute (NCI)
Phase 2B
OMBURTAMAB
Memorial Sloan Kettering Cancer Center
Phase 2CCC
Thiotepa
M.D. Anderson Cancer Center
Phase 2CCC
TACROLIMUS
M.D. Anderson Cancer Center
Phase 2CCC

View all 29 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →